Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ABIONYX Pharma - Filing #2813091

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
:
Reserve of exchange differences on translation
126,000 EUR
87,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
8 251 EUR
8 821 EUR
Current assets
7 572 EUR
13 011 EUR
Non-current liabilities
3 560 EUR
4 408 EUR
Current liabilities
5 094 EUR
6 747 EUR
Revenue
5 252 EUR
675,000 EUR
Profit (loss)
4 206 EUR
4 206 EUR
5 822 EUR
5 822 EUR
Comprehensive income
3 985 EUR
5 759 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.